Daniela Göppner

2.4k total citations
16 papers, 248 citations indexed

About

Daniela Göppner is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniela Göppner has authored 16 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniela Göppner's work include Cutaneous Melanoma Detection and Management (8 papers), Melanoma and MAPK Pathways (7 papers) and Optical Coherence Tomography Applications (3 papers). Daniela Göppner is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Melanoma and MAPK Pathways (7 papers) and Optical Coherence Tomography Applications (3 papers). Daniela Göppner collaborates with scholars based in Germany, Austria and Switzerland. Daniela Göppner's co-authors include Martin Leverkus, Harald Gollnick, Rudolf Herbst, Carmen Loquai, Erwin Schultz, Susanne G. Schäd, Thilo Gambichler, Fanny Matheis, Thomas Eigentler and Edgar Dippel and has published in prestigious journals such as Annals of Oncology, Frontiers in Immunology and European Journal of Cancer.

In The Last Decade

Daniela Göppner

15 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Göppner Germany 10 103 85 54 47 47 16 248
Chiara Astrua Italy 9 171 1.7× 114 1.3× 35 0.6× 68 1.4× 12 0.3× 22 322
Amira Sanki Australia 9 322 3.1× 222 2.6× 69 1.3× 28 0.6× 13 0.3× 12 421
Michael J. Carr United States 11 262 2.5× 85 1.0× 45 0.8× 26 0.6× 9 0.2× 32 355
Claudia von Arx Italy 11 219 2.1× 100 1.2× 114 2.1× 7 0.1× 38 0.8× 31 461
Gabriela Turcu Romania 10 288 2.8× 117 1.4× 31 0.6× 38 0.8× 13 0.3× 26 463
Raimondo Di Giacomo Italy 10 87 0.8× 78 0.9× 23 0.4× 7 0.1× 124 2.6× 24 384
Felix Weihsengruber Austria 8 122 1.2× 39 0.5× 69 1.3× 90 1.9× 7 0.1× 15 253
Karen Sielaff United States 9 112 1.1× 87 1.0× 46 0.9× 22 0.5× 11 0.2× 11 333
Dolgor Baatar United States 9 226 2.2× 114 1.3× 33 0.6× 25 0.5× 22 0.5× 9 500
Marie Viala France 10 185 1.8× 68 0.8× 20 0.4× 144 3.1× 6 0.1× 25 418

Countries citing papers authored by Daniela Göppner

Since Specialization
Citations

This map shows the geographic impact of Daniela Göppner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Göppner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Göppner more than expected).

Fields of papers citing papers by Daniela Göppner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Göppner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Göppner. The network helps show where Daniela Göppner may publish in the future.

Co-authorship network of co-authors of Daniela Göppner

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Göppner. A scholar is included among the top collaborators of Daniela Göppner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Göppner. Daniela Göppner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Sadik, Christian D., Ewan A. Langan, Ralf Gutzmer, et al.. (2021). Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers. Frontiers in Immunology. 11. 588582–588582. 28 indexed citations
4.
Zimmer, Lisa, Elisabeth Livingstone, Angela M. Krackhardt, et al.. (2021). Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV600 mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial. European Journal of Cancer. 158. 72–84. 17 indexed citations
5.
6.
Mohnike, Konrad, Klaus Neumann, Peter Hass, et al.. (2017). Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy. Strahlentherapie und Onkologie. 193(8). 612–619. 13 indexed citations
7.
Göppner, Daniela, et al.. (2017). Indocyanine green‐assisted sentinel lymph node biopsy in melanoma using the “FOVIS“ system. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 15(2). 169–178. 17 indexed citations
8.
Heppt, Markus V., Thomas Eigentler, Katharina C. Kähler, et al.. (2016). Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunology Immunotherapy. 65(8). 951–959. 60 indexed citations
9.
Mohnike, Konrad, Peter Hass, Ricarda Seidensticker, et al.. (2015). Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma. Journal of Contemporary Brachytherapy. 2(2). 154–160. 10 indexed citations
10.
Ulrich, Martina, Daniela Göppner, Harald Gollnick, et al.. (2015). Technical parameters of verticalin vivomultiphoton microscopy: a critical evaluation of the flyscanning method. Laser Physics Letters. 12(8). 85602–85602. 10 indexed citations
11.
Göppner, Daniela, Joachim Müller, Stefan Krüger, et al.. (2014). High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib. Acta Dermato Venereologica. 94(5). 517–520. 20 indexed citations
12.
Göppner, Daniela, et al.. (2011). Wide-field, high-resolution two-photon tissue mapping of human skin ex vivo. Medical Laser Application. 26(4). 158–165. 3 indexed citations
13.
Göppner, Daniela & Martin Leverkus. (2011). Prognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?. Journal of Skin Cancer. 2011. 1–13. 7 indexed citations
14.
Göppner, Daniela, Jens Ulrich, Anna Pokrywka, et al.. (2010). Sentinel Lymph Node Biopsy Status Is a Key Parameter to Stratify the Prognostic Heterogeneity of Malignant Melanoma in High-Risk Tumors >4.0 mm. Dermatology. 222(1). 59–66. 12 indexed citations
15.
Göppner, Daniela, Sven Quist, Ingolf Franke, et al.. (2010). Selective regional perfusion of the bilateral external carotid arteries with pegylated liposomal doxorubicin and melphalan to treat metastatic malignant melanoma of the scalp. Clinical and Experimental Dermatology. 36(3). 270–272. 1 indexed citations
16.
Göppner, Daniela & Martin Leverkus. (2010). Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease. Journal of Skin Cancer. 2011. 1–8. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Astrua Breakdown of academic impact, for papers by Amira Sanki Breakdown of academic impact, for papers by Michael J. Carr Breakdown of academic impact, for papers by Claudia von Arx Breakdown of academic impact, for papers by Gabriela Turcu Breakdown of academic impact, for papers by Raimondo Di Giacomo Breakdown of academic impact, for papers by Felix Weihsengruber Breakdown of academic impact, for papers by Karen Sielaff Breakdown of academic impact, for papers by Dolgor Baatar Breakdown of academic impact, for papers by Marie Viala
Rankless by CCL
2026